University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 14 of 27
Reducing Inappropriate Benzodiazepine Use Among Older Adults
NCT03405298
Development of a Tailored Life-Sustaining Treatment Decision Support Intervention for Stroke Surrogate Decision Makers
NCT03427645
Mood Lifters: A Self Help Program
NCT02558075
EIT Assessment of Lung Volume and Tidal Distribution: A Comparison of Non-Invasive Ventilation Devices
NCT02930174
Effects of Provider Commitments to Choose Wisely
NCT03411525
Explore Effects of Dietary Fish Oil in Human Skin
NCT03122912
MI-BP: mHealth to Improve Blood Pressure Control
NCT02955537
Evaluation of Patient Experience and Quality of Life During In Vitro Fertilization Treatment
NCT03383848
Yoga for Fatigue in the Survivors of Bone Marrow Transplantation
NCT03299465
Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients?
NCT03262038
Auto-PAP Therapy For Improved Fetal Growth
NCT03318003
Pharmacogenomic Testing in Primary Care
NCT03270891
Functional Remediation for Bipolar Disorder
NCT03403179
Resilience Skills Self-Management for Chronic Pain.
NCT03304613
Tracking Physical Activity for Chronic Pain Management Among Older Adults in Detroit
NCT03285958
Cognitive Behavioral Therapy for Insomnia: Face-to-Face Versus Telemedicine
NCT03293745
Validation of Sleep Apnea Screening Device Phase II
NCT03025464
Comparative Tests of Flu Vaccination Phone Messages
NCT03332992
An Evaluation of the Michigan State Innovation Model in Washtenaw and Livingston Counties
NCT03293160
Adipose Tissue Cellular Response to Exercise in Healthy Humans
NCT03314506
Effects of Inspiratory Muscle Training in Persons With Advanced Multiple Sclerosis
NCT03345199
Evaluation of an Interactive Opioid Risk Education Program (STOMP) for Parents
NCT03287622
A Pilot Study Testing a Life Skills Application to Address Interpersonal Relationships in College
NCT03316911
Infant Mental Health-Home Visiting Randomized Controlled Trial
NCT03175796
Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER
NCT03079856
The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life
NCT03304184
Real-Time Decision Support for Improving Intraoperative Cerebral Perfusion Pressure
NCT03285971
Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)
NCT03274076
Tailored Messaging to Reduce Sodium Intake
NCT03099343
Conditioning Brain Responses to Improve Thigh Muscle Function After Anterior Cruciate Ligament Reconstruction
NCT03209531
OPTIMA-TBI Pilot Study
NCT03345550
A PATH (Promoting Activity and Trajectories of Health) for Children
NCT03189862
A Low-Carbohydrate Diabetes Prevention Program
NCT03258918
Helping People With Health Conditions Make Birth Control Decisions
NCT03153644
Implementing Technology Enhanced Real Time Action Observation Therapy in Persons With Chronic Stroke
NCT03780296
RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative
NCT02867761
The Role of Food Sensitivity in Psoriasis
NCT03084146
SARA - Substance Abuse Research Assistant
NCT03255317
Skin Tape Harvesting for Transcriptomics Analysis
NCT03048721
Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon
NCT03220711
Active for Life: Chronic Obstructive Pulmonary Disease
NCT03201198
Network-Level Effects of Nitrous Oxide in the Human Brain
NCT03435055
Noninvasive Negative Pressure Ventilation to Support Failing Fontan Physiology
NCT03223168
Effects of Karate in Adolescents With Down Syndrome
NCT03058640
Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection
NCT03349268
Diet Reintroduction Study in Irritable Bowel Syndrome
NCT03052439
Population Effects of MI on Pediatric Obesity in Primary Care
NCT03177148
Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Project #3 - Experiment 3 [UdallP3E3])
NCT04403399
Optimal Care of Complicated Appendicitis
NCT03159754
Correlating Brain Tissue Oxygen and Regional Cerebral Oximetry
NCT03128957
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.